logo
Select company
Select metric
46.76%Debt to Assets Ratio
VS
Market
21
Sector
17
Industry
15
History
-
$ 11.73Close
$ 5.31 - $ 12.34 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 581.03M$ 271.69M46.76%
3/31/2025$ 490.93M$ 133.53M27.2%
12/31/2024$ 465.99M$ 141.72M30.41%
9/30/2024$ 519.11M$ 145.81M28.09%
6/30/2024$ 569.38M$ 158.72M27.88%
3/31/2024$ 629.22M$ 170.57M27.11%
12/31/2023$ 573.97M$ 183.34M31.94%
9/30/2023$ 633.79M$ 196.54M31.01%
6/30/2023$ 682.46M$ 207.92M30.47%
3/31/2023$ 747.83M$ 220.41M29.47%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) Debt to Assets stands at 11.28%.
  • Over the past 5 years, REGENXBIO INC's average Debt to Assets has been 29.13%.
  • The median Debt to Assets for REGENXBIO INC during this period was 28.78%
  • REGENXBIO INC reached its highest Debt to Assets over the past 5 years at 46.76%.
  • The lowest Debt to Assets recorded by REGENXBIO INC in the same timeframe 11.28%

REGENXBIO INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
CTMX : CYTOMX THERAPEUTICS INC 3.93%XNCR : XENCOR INC 24.22%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 7.42%YMAB : Y-MABS THERAPEUTICS INC 2.67%GLUE : MONTE ROSA THERAPEUTICS INC 11.44%HRTX : HERON THERAPEUTICS INC 76.15%NKTR : NEKTAR THERAPEUTICS 46.33%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC 84.71%LXRX : LEXICON PHARMACEUTICALS INC 24.87%VNDA : VANDA PHARMACEUTICALS INC 1.11%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for REGENXBIO INC is calculated as follows: Debt [ $ 61.02M ] / Assets [ $ 541.17M ]
(=) Debt to Assets [ 11.28% ]

RGNX - Debt to Assets Ratio, Last 5 years

11.28%

Minimum

Sep 30, 2020

46.76%

Maximum

Jun 30, 2025

29.13%

Average

28.78%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.51%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.51%